Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:regulatory_procedure
|
| gptkbp:administeredBy |
gptkb:World_Health_Organization
|
| gptkbp:appliesTo |
vaccines
therapeutics diagnostics |
| gptkbp:criteria |
safety
quality efficacy |
| gptkbp:enables |
gptkb:emergency_use_authorization
expedited assessment |
| gptkbp:introducedIn |
2014
|
| gptkbp:notableFor |
gptkb:COVID-19_vaccines
|
| gptkbp:purpose |
facilitate availability of medical products during public health emergencies
|
| gptkbp:relatedTo |
prequalification process
|
| gptkbp:website |
https://www.who.int/initiatives/emergency-use-listing
|
| gptkbp:bfsParent |
gptkb:Covaxin
|
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Emergency Use Listing (EUL)
|